Comparison of Composite Measure Remission Targets in Psoriatic Arthritis.

Flora Farkas Natsumi Ikumi Musaab Elmamoun Agnes Szentpetery Oliver M FitzGerald

Published in: The Journal of rheumatology (2021)

Based on our analysis, VLDA proved the most stringent target of disease remission in PsA compared to CPDAI, DAPSA, and cDAPSA. The pain VAS target of ≤ 1.5 cm was the most difficult component to achieve. CPDAI ≤ 2 was found to be the least stringent remission target; however, measurements of axial involvement, which contributed to the elevated pain VAS score in patients not achieving VLDA, were included as a domain in CPDAI only.

Keyphrases

chronic pain
end stage renal disease
disease activity
pain management
prostate cancer
newly diagnosed
ulcerative colitis
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
rheumatoid arthritis
radical prostatectomy